- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00877825
The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy
April 7, 2009 updated by: University of Toronto
Isoflavonoids, through their estrogen-like activity, are in part responsible for the cholesterol lowering properties of soy foods.
If this is found to be so, then it would be advantageous not only to promote soy consumption, but also to identify and use soy cultivars with high isoflavonoid content in production of soy food products.
These foods may have a use in the reduction of serum cholesterol and if they effectively increase the phytoestrogen activity of soy, may have a role in the prevention of other hormone dependent diseases (e.g.
osteoporosis, certain cancers) in the same way as natural estrogens.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 2
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- men and post-menopausal women
- LDL-C > 4.1mmol/L at recruitment
- living within a 40 km radius of St. Michael's Hospital
Exclusion Criteria:
- lipid lowering medications
- clinical or biochemical evidence of diabetes, renal or hepatic disease
- body mass index (BMI) >38 kg/m2
- antibiotic use within the last three months
- hormone replacement therapy
- smoking or significant alcohol use (>1 drink/d)
- triglyceride level > 4.0mmol/L
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Completion (ACTUAL)
April 1, 2000
Study Registration Dates
First Submitted
April 3, 2009
First Submitted That Met QC Criteria
April 7, 2009
First Posted (ESTIMATE)
April 8, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
April 8, 2009
Last Update Submitted That Met QC Criteria
April 7, 2009
Last Verified
April 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB235U
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on dairy food control diet and high- and low- isoflavone soyfood diets
-
Oslo University HospitalCompletedIrritable Bowel Syndrome | Diet Modification | Celiac Disease | Gluten SensitivityNorway
-
University Hospital, RouenCompleted
-
University of BariCompletedFunctional Gastrointestinal Disorders | IBSItaly
-
Warsaw University of Life SciencesCompletedSmall Intestinal Bacterial Overgrowth | SIBO | Small Intestinal Bacterial Overgrowth Syndrome (SIBO)Poland
-
University of MinnesotaCompleted
-
University Hospital, BordeauxCompleted
-
University of AarhusEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityNot yet recruitingIrritable Bowel Syndrome
-
University Hospital Inselspital, BerneCompletedRenal Failure | Renal Transplantation | Living DonorsSwitzerland
-
University of TorontoCompletedCardiovascular Disease | Type 2 DiabetesCanada